Marshall Wace’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,979
| Closed | -$253K | – | 2267 |
|
|
2024
Q2 | $253K | Buy |
+3,979
| New | +$253K | ﹤0.01% | 2022 |
|
|
2023
Q4 | – | Sell |
-89,093
| Closed | -$5.17M | – | 1812 |
|
|
2023
Q3 | $5.17M | Buy |
89,093
+78,847
| +770% | +$4.58M | 0.01% | 764 |
|
|
2023
Q2 | $552K | Sell |
10,246
-953
| -9% | -$51.3K | ﹤0.01% | 1555 |
|
|
2023
Q1 | $445K | Buy |
+11,199
| New | +$445K | ﹤0.01% | 1689 |
|
|
2022
Q1 | – | Sell |
-44,600
| Closed | -$2.06M | – | 2580 |
|
|
2021
Q4 | $2.06M | Buy |
+44,600
| New | +$2.06M | ﹤0.01% | 1608 |
|
|
2019
Q2 | – | Sell |
-11,303
| Closed | -$797K | – | 1289 |
|
|
2019
Q1 | $797K | Buy |
+11,303
| New | +$797K | 0.01% | 1001 |
|
|
2018
Q4 | – | Sell |
-9,289
| Closed | -$525K | – | 1566 |
|
|
2018
Q3 | $525K | Buy |
+9,289
| New | +$525K | ﹤0.01% | 913 |
|